Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran.
about
Systems biology and biomarkers of early effects for occupational exposure limit settingEvaluation of relative effect potencies (REPs) for dioxin-like compounds to derive systemic or human-specific TEFs to improve human risk assessmentPutative Epimutagens in Maternal Peripheral and Cord Blood Samples Identified Using Human Induced Pluripotent Stem CellsSource-Related Effects of Wastewater on Transcription Factor (AhR, CAR and PXR)-Mediated Induction of Gene Expression in Cultured Rat Hepatocytes and Their Association with the Prevalence of Antimicrobial-Resistant Escherichia coliComparison of TCDD-elicited genome-wide hepatic gene expression in Sprague-Dawley rats and C57BL/6 mice.Intersection of AHR and Wnt signaling in development, health, and disease.Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context.Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytesRecent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study.The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events.Aryl hydrocarbon receptor-based bioassays for dioxin detection: Thinking outside the box.
P2860
Q23911416-DB634F86-0CE2-44CE-B51E-96B2CC50ACBAQ26751039-BED91144-1571-49FE-B1F3-FEA79FA0B778Q28385927-71AC8954-0643-44EA-8F3C-F5EC71A83E80Q28389019-46E3F29B-374B-416F-9806-1EB475CFB681Q33923892-9D808A06-765F-47CD-90C8-458FC984D6B9Q34486670-5C836DF8-0547-49EB-AC2F-EF3629CDC7E8Q36447531-539CFA0F-D374-403C-A14D-2347C6BF9C90Q36769360-BB47CB41-7B1B-4E2A-BD52-3529CB4E6C97Q37121662-FB55FE91-2440-4D77-9B58-BA61C62CC688Q38163594-39FE65F5-6AFC-41B1-B951-C8E4C78DA201Q38234794-DF9EBDD9-0FC0-4B93-85BA-CE7E8F07D7B3Q47254625-0D146F67-93D1-48C2-BD00-24B8F8DB8CE6
P2860
Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Human and rat primary hepatocy ...... 4,7,8-pentachlorodibenzofuran.
@en
Human and rat primary hepatocy ...... 4,7,8-pentachlorodibenzofuran.
@nl
type
label
Human and rat primary hepatocy ...... 4,7,8-pentachlorodibenzofuran.
@en
Human and rat primary hepatocy ...... 4,7,8-pentachlorodibenzofuran.
@nl
prefLabel
Human and rat primary hepatocy ...... 4,7,8-pentachlorodibenzofuran.
@en
Human and rat primary hepatocy ...... 4,7,8-pentachlorodibenzofuran.
@nl
P2093
P2860
P356
P1476
Human and rat primary hepatocy ...... ,4,7,8-pentachlorodibenzofuran
@en
P2093
J Craig Rowlands
Robert A Budinsky
Stephen S Ferguson
P2860
P304
P356
10.1093/TOXSCI/KFQ238
P577
2010-08-12T00:00:00Z